Skip to main content

Table 4 Results from statistical modelling (Random effects Model)

From: Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

  EQ-5D-5L EQ-5D-3L
  Estimate SE P-value Estimate SE P-value
Intercept 0.2255 0.09157 0.0142 0.08046 0.08507 0.3450
Physical Functioning 0.006418* 0.000676 <.0001 0.006137* 0.000620 <.0001
Role Functioning -0.00032 0.000591 0.5935 0.001392* 0.000509 0.0066
Emotional Functioning 0.001871* 0.000554 0.0008 0.001949* 0.000481 <.0001
Cognitive Functioning -0.00057 0.000491 0.2436 -0.00073 0.000448 0.1024
Social Functioning 0.000387 0.000530 0.4664 0.000516 0.000462 0.2652
Global health status / QoL -0.00109* 0.000409 0.0082 -0.00043 0.000401 0.2853
Fatigue 0.000324 0.000696 0.6420 0.000993 0.000647 0.1261
Nausea / Vomiting -0.00041 0.000600 0.4990 0.000276 0.000524 0.5993
Pain -0.00311* 0.000495 <.0001 -0.00215* 0.000427 <.0001
Dyspnoea 0.000368 0.000464 0.4287 -0.00011 0.000421 0.7915
Insomnia -0.00017 0.000338 0.6218 -0.00004 0.000313 0.9053
Appetite loss -0.00030 0.000328 0.3673 0.000341 0.000295 0.2488
Constipation -0.00013 0.000359 0.7139 0.000524 0.000306 0.0877
Diarhoea 0.001155* 0.000438 0.0087 0.000499 0.000425 0.2409
Financial Problems 0.000345 0.000334 0.3019 -0.00004 0.000297 0.9039
  1. *Statistically significant at the two-sided 5 % level